아르보바이러스 검사 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for arbovirus testing. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global arbovirus testing market from 2025 to 2032.

Key Insights:

• Arbovirus Testing Market Size (2025E): USD 1,094.4 Million
• Projected Market Value (2032F): USD 1,521.1 Million
• Global Market Growth Rate (CAGR 2025 to 2032): 4.8%

Arbovirus Testing Market - Report Scope:

Arbovirus testing plays a vital role in the diagnosis and surveillance of arthropod-borne viral infections such as dengue, Zika, chikungunya, yellow fever, and West Nile virus. These diseases are primarily transmitted by mosquitoes and ticks, posing significant public health challenges, particularly in tropical and subtropical regions. The arbovirus testing market comprises molecular diagnostics, serological tests, and point-of-care assays, used in hospitals, clinics, laboratories, and field surveillance programs. The increasing prevalence of arboviral outbreaks, coupled with rising global mobility and climate change effects on vector ecology, is driving demand for advanced diagnostic solutions.

Market Growth Drivers:

The global arbovirus testing market is propelled by the escalating incidence of arboviral diseases worldwide, driven by factors such as urbanization, global travel, and environmental changes that favor mosquito breeding. Rising government and non-governmental funding for infectious disease control and public health preparedness has spurred investments in disease surveillance and diagnostics infrastructure. Advancements in molecular diagnostic technologies, including PCR and next-generation sequencing, have enabled faster and more accurate detection of arboviruses, facilitating early intervention and outbreak containment. In addition, growing awareness and implementation of screening programs in endemic regions support market growth.

Market Restraints:

Despite the promising outlook, the market faces challenges including limited accessibility of diagnostic tools in low-income regions, lack of standardized testing protocols, and shortage of trained laboratory personnel. High costs associated with molecular tests and limited insurance coverage in some countries further restrict market penetration. Seasonal and outbreak-driven demand variability also affects production planning and resource allocation for manufacturers. Moreover, cross-reactivity in serological testing methods, particularly among flaviviruses, may lead to misdiagnosis, impacting test reliability and clinical decision-making.

Market Opportunities:

The arbovirus testing market presents substantial growth opportunities through innovations in portable, point-of-care diagnostic devices, which offer rapid results and are suitable for field use during outbreaks. Integration of artificial intelligence and data analytics in epidemiological modeling enhances disease forecasting and test deployment strategies. Increasing public-private partnerships for R&D and the emergence of multiplex assays capable of simultaneously detecting multiple arboviruses can streamline workflows and reduce diagnostic costs. Expansion of testing in non-endemic regions due to travel-related transmission and the establishment of global disease surveillance networks further open avenues for market expansion.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the arbovirus testing market globally?
• Which testing technologies and platforms are gaining traction in endemic and non-endemic regions?
• How are innovations in molecular diagnostics influencing the arbovirus testing landscape?
• Who are the key players in the arbovirus testing market, and what strategies are they employing to remain competitive?
• What are the emerging trends and future prospects in the global arbovirus testing market?

Competitive Intelligence and Business Strategy:

Leading players in the global arbovirus testing market, including Abbott Laboratories, Thermo Fisher Scientific Inc., bioMerieux SA, and Bio-Rad Laboratories, Inc., are focusing on technology development, strategic collaborations, and geographical expansion to enhance their market presence. These companies are investing in advanced diagnostic platforms and launching rapid, multiplex, and high-throughput testing kits to address increasing demand for accurate and timely diagnostics. Partnerships with public health agencies and academic institutions support surveillance initiatives and product innovation. Continuous focus on regulatory approvals, training programs, and awareness campaigns is aiding in expanding market access, particularly in resource-limited settings.

Key Companies Profiled:

• Abbott Laboratories
• Roche Diagnostics
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Siemens Healthineers AG
• Danaher Corporation (includes Cepheid, Beckman Coulter)
• QIAGEN N.V.
• bioMerieux SA
• Meridian Bioscience, Inc.
• NovaTec Immundiagnostica GmbH
• InBios International, Inc.
• Artron Laboratories Inc.
• SD Biosensor, Inc.
• CTK Biotech, Inc.
• Euroimmun AG (a PerkinElmer company)
• Others

Market Segmentation

By Test Type

• Serological Tests
• Molecular Diagnostic Tests
• Others

By Virus Type

• Dengue Virus
• Zika Virus
• Chikungunya Virus
• Yellow Fever Virus
• West Nile Virus
• Japanese Encephalitis Virus
• Others

By End-user

• Hospitals & Clinics
• Diagnostic Laboratories
• Research Centers
• Public Health Agencies
• Academic Institutions

By Region

• North America
• Europe
• East Asia
• South Asia and Oceania
• Latin America
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Arbovirus Testing Market Snapshot, 2025-2032
• 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Regulatory Landscape
• 3.2. Test Type Adoption Analysis
• 3.3. Technological Advancements
• 3.4. Disease Epidemiology
• 3.5. Value Chain Analysis
• 3.6. Key Deals and Mergers
• 3.7. PESTLE Analysis
• 3.8. Porter's Five Force Analysis

4. Global Arbovirus Testing Market Outlook:

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Mn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
• 4.3. Global Arbovirus Testing Market Outlook: Test Type
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Test Type, 2019-2024
  • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
    • 4.3.3.1. Serological Tests
    • 4.3.3.2. Molecular Diagnostic Tests
    • 4.3.3.3. Others
  • 4.3.4. Market Attractiveness Analysis: Test Type
• 4.4. Global Arbovirus Testing Market Outlook: Virus Type
  • 4.4.1. Introduction / Key Findings
  • 4.4.2. Historical Market Size (US$ Mn) Analysis, By Virus Type, 2019-2024
  • 4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
    • 4.4.3.1. Dengue Virus
    • 4.4.3.2. Zika Virus
    • 4.4.3.3. Chikungunya Virus
    • 4.4.3.4. Yellow Fever Virus
    • 4.4.3.5. West Nile Virus
    • 4.4.3.6. Japanese Encephalitis Virus
    • 4.4.3.7. Others
  • 4.4.4. Market Attractiveness Analysis: Virus Type
• 4.5. Global Arbovirus Testing Market Outlook: End User
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
  • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 4.5.3.1. Hospitals & Clinics
    • 4.5.3.2. Diagnostic Laboratories
    • 4.5.3.3. Research Centers
    • 4.5.3.4. Public Health Agencies
    • 4.5.3.5. Academic Institutions
  • 4.5.4. Market Attractiveness Analysis: End User

5. Global Arbovirus Testing Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
• 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Arbovirus Testing Market Outlook:

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 6.2.1. By Country
  • 6.2.2. By Test Type
  • 6.2.3. By Virus Type
  • 6.2.4. By End User
• 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
  • 6.4.1. Serological Tests
  • 6.4.2. Molecular Diagnostic Tests
  • 6.4.3. Others
• 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
  • 6.5.1. Dengue Virus
  • 6.5.2. Zika Virus
  • 6.5.3. Chikungunya Virus
  • 6.5.4. Yellow Fever Virus
  • 6.5.5. West Nile Virus
  • 6.5.6. Japanese Encephalitis Virus
  • 6.5.7. Others
• 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 6.6.1. Hospitals & Clinics
  • 6.6.2. Diagnostic Laboratories
  • 6.6.3. Research Centers
  • 6.6.4. Public Health Agencies
  • 6.6.5. Academic Institutions
• 6.7. Market Attractiveness Analysis

7. Europe Arbovirus Testing Market Outlook:

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 7.2.1. By Country
  • 7.2.2. By Test Type
  • 7.2.3. By Virus Type
  • 7.2.4. By End User
• 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkey
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
  • 7.4.1. Serological Tests
  • 7.4.2. Molecular Diagnostic Tests
  • 7.4.3. Others
• 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
  • 7.5.1. Dengue Virus
  • 7.5.2. Zika Virus
  • 7.5.3. Chikungunya Virus
  • 7.5.4. Yellow Fever Virus
  • 7.5.5. West Nile Virus
  • 7.5.6. Japanese Encephalitis Virus
  • 7.5.7. Others
• 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 7.6.1. Hospitals & Clinics
  • 7.6.2. Diagnostic Laboratories
  • 7.6.3. Research Centers
  • 7.6.4. Public Health Agencies
  • 7.6.5. Academic Institutions
• 7.7. Market Attractiveness Analysis

8. East Asia Arbovirus Testing Market Outlook:

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 8.2.1. By Country
  • 8.2.2. By Test Type
  • 8.2.3. By Virus Type
  • 8.2.4. By End User
• 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
  • 8.4.1. Serological Tests
  • 8.4.2. Molecular Diagnostic Tests
  • 8.4.3. Others
• 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
  • 8.5.1. Dengue Virus
  • 8.5.2. Zika Virus
  • 8.5.3. Chikungunya Virus
  • 8.5.4. Yellow Fever Virus
  • 8.5.5. West Nile Virus
  • 8.5.6. Japanese Encephalitis Virus
  • 8.5.7. Others
• 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 8.6.1. Hospitals & Clinics
  • 8.6.2. Diagnostic Laboratories
  • 8.6.3. Research Centers
  • 8.6.4. Public Health Agencies
  • 8.6.5. Academic Institutions
• 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Arbovirus Testing Market Outlook:

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 9.2.1. By Country
  • 9.2.2. By Test Type
  • 9.2.3. By Virus Type
  • 9.2.4. By End User
• 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
  • 9.4.1. Serological Tests
  • 9.4.2. Molecular Diagnostic Tests
  • 9.4.3. Others
• 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
  • 9.5.1. Dengue Virus
  • 9.5.2. Zika Virus
  • 9.5.3. Chikungunya Virus
  • 9.5.4. Yellow Fever Virus
  • 9.5.5. West Nile Virus
  • 9.5.6. Japanese Encephalitis Virus
  • 9.5.7. Others
• 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 9.6.1. Hospitals & Clinics
  • 9.6.2. Diagnostic Laboratories
  • 9.6.3. Research Centers
  • 9.6.4. Public Health Agencies
  • 9.6.5. Academic Institutions
• 9.7. Market Attractiveness Analysis

10. Latin America Arbovirus Testing Market Outlook:

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 10.2.1. By Country
  • 10.2.2. By Test Type
  • 10.2.3. By Virus Type
  • 10.2.4. By End User
• 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
  • 10.4.1. Serological Tests
  • 10.4.2. Molecular Diagnostic Tests
  • 10.4.3. Others
• 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
  • 10.5.1. Dengue Virus
  • 10.5.2. Zika Virus
  • 10.5.3. Chikungunya Virus
  • 10.5.4. Yellow Fever Virus
  • 10.5.5. West Nile Virus
  • 10.5.6. Japanese Encephalitis Virus
  • 10.5.7. Others
• 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 10.6.1. Hospitals & Clinics
  • 10.6.2. Diagnostic Laboratories
  • 10.6.3. Research Centers
  • 10.6.4. Public Health Agencies
  • 10.6.5. Academic Institutions
• 10.7. Market Attractiveness Analysis

11. Middle East & Africa Arbovirus Testing Market Outlook:

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
  • 11.2.1. By Country
  • 11.2.2. By Test Type
  • 11.2.3. By Virus Type
  • 11.2.4. By End User
• 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Test Type, 2025-2032
  • 11.4.1. Serological Tests
  • 11.4.2. Molecular Diagnostic Tests
  • 11.4.3. Others
• 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Virus Type, 2025-2032
  • 11.5.1. Dengue Virus
  • 11.5.2. Zika Virus
  • 11.5.3. Chikungunya Virus
  • 11.5.4. Yellow Fever Virus
  • 11.5.5. West Nile Virus
  • 11.5.6. Japanese Encephalitis Virus
  • 11.5.7. Others
• 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  • 11.6.1. Hospitals & Clinics
  • 11.6.2. Diagnostic Laboratories
  • 11.6.3. Research Centers
  • 11.6.4. Public Health Agencies
  • 11.6.5. Academic Institutions
• 11.7. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2025
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Abbott Laboratories
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Test Types
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. Roche Diagnostics
  • 12.3.3. Thermo Fisher Scientific Inc.
  • 12.3.4. Bio-Rad Laboratories, Inc.
  • 12.3.5. Siemens Healthineers AG
  • 12.3.6. Danaher Corporation (includes Cepheid, Beckman Coulter)
  • 12.3.7. QIAGEN N.V.
  • 12.3.8. bioMerieux SA
  • 12.3.9. Meridian Bioscience, Inc.
  • 12.3.10. NovaTec Immundiagnostica GmbH
  • 12.3.11. InBios International, Inc.
  • 12.3.12. Artron Laboratories Inc.
  • 12.3.13. SD Biosensor, Inc.
  • 12.3.14. CTK Biotech, Inc.
  • 12.3.15. Euroimmun AG (a PerkinElmer company)
  • 12.3.16. Others

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations